Alembic (India) Performance
| ALEMBICLTD | 131.23 1.67 1.29% |
The firm shows a Beta (market volatility) of 0.34, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Alembic's returns are expected to increase less than the market. However, during the bear market, the loss of holding Alembic is expected to be smaller as well. At this point, Alembic Limited has a negative expected return of -0.27%. Please make sure to confirm Alembic's potential upside, day median price, and the relationship between the total risk alpha and accumulation distribution , to decide if Alembic Limited performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Alembic Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Forward Dividend Yield 0.0179 | Payout Ratio 0.2018 | Last Split Factor 2:1 | Forward Dividend Rate 2.4 | Ex Dividend Date 2024-08-05 |
1 | Stocks to buy Alembic Pharma to Hind CopperSMC Global Securities lists four stocks to bet on this week - MSN | 09/05/2024 |
2 | Alembic Pharma gets USFDA nod for hypertension treatment drug - CNBCTV18 | 11/11/2024 |
| Begin Period Cash Flow | 9.3 M |
Alembic |
Alembic Relative Risk vs. Return Landscape
If you would invest 15,836 in Alembic Limited on August 30, 2024 and sell it today you would lose (2,713) from holding Alembic Limited or give up 17.13% of portfolio value over 90 days. Alembic Limited is generating negative expected returns and assumes 2.3571% volatility on return distribution over the 90 days horizon. Simply put, 20% of stocks are less volatile than Alembic, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Alembic Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alembic's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Alembic Limited, and traders can use it to determine the average amount a Alembic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1147
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALEMBICLTD |
Estimated Market Risk
| 2.36 actual daily | 21 79% of assets are more volatile |
Expected Return
| -0.27 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Alembic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alembic by adding Alembic to a well-diversified portfolio.
Alembic Fundamentals Growth
Alembic Stock prices reflect investors' perceptions of the future prospects and financial health of Alembic, and Alembic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Alembic Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0135 | ||||
| Profit Margin | 1.63 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 32.88 B | ||||
| Shares Outstanding | 256.78 M | ||||
| Price To Book | 1.48 X | ||||
| Price To Sales | 19.42 X | ||||
| Revenue | 1.57 B | ||||
| Gross Profit | 928.92 M | ||||
| EBITDA | 1.05 B | ||||
| Net Income | 1.03 B | ||||
| Cash And Equivalents | 9.32 M | ||||
| Total Debt | 91.49 M | ||||
| Book Value Per Share | 85.11 X | ||||
| Cash Flow From Operations | 226.87 M | ||||
| Earnings Per Share | 12.09 X | ||||
| Total Asset | 23.29 B | ||||
| Retained Earnings | 14.81 B | ||||
About Alembic Performance
By analyzing Alembic's fundamental ratios, stakeholders can gain valuable insights into Alembic's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Alembic has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Alembic has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Alembic is entity of India. It is traded as Stock on NSE exchange.Things to note about Alembic Limited performance evaluation
Checking the ongoing alerts about Alembic for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Alembic Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Alembic Limited generated a negative expected return over the last 90 days | |
| About 72.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Alembic Pharma gets USFDA nod for hypertension treatment drug - CNBCTV18 |
- Analyzing Alembic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alembic's stock is overvalued or undervalued compared to its peers.
- Examining Alembic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Alembic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alembic's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Alembic's stock. These opinions can provide insight into Alembic's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Alembic Stock analysis
When running Alembic's price analysis, check to measure Alembic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alembic is operating at the current time. Most of Alembic's value examination focuses on studying past and present price action to predict the probability of Alembic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alembic's price. Additionally, you may evaluate how the addition of Alembic to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |